SCHEMBL8968592

SCHEMBL8968592

O=C(N[C@@H](CCCN1C(=O)c2ccccc2C1=O)C(=O)O)OCc1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.53
CYP2D6 P10635 1/20 0.53
CYP2C9 P11712 1/20 0.53
CYP2C19 P33261 1/20 0.53
RAB9A P51151 1/20 0.53
FOLH1 Q04609 2/20 0.50
SIRT2 Q8IXJ6 1/20 0.50
SIRT1 Q96EB6 1/20 0.50
IDO1 P14902 1/20 0.49
TDO2 P48775 1/20 0.49
CTSL P07711 1/20 0.48
CTSS P25774 1/20 0.48
ITGB3 P05106 5/20 0.48
ITGAV P06756 2/20 0.48
ITGA2B P08514 3/20 0.48
TGM2 P21980 1/20 0.47
CASP1 P29466 1/20 0.47
ITGA4 P13612 1/20 0.46
ITGB7 P26010 1/20 0.46
MMP2 P08253 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2004222 1.00 CYP3A4 (0.53) CYP3A4CYP2D6CYP2C9CYP2C19RAB9A
SCHEMBL12087999 0.97 CYP3A4 (0.53) CYP3A4CYP2D6CYP2C9CYP2C19RAB9A
SCHEMBL12088102 0.95 SIRT2 (0.53) CYP3A4CYP2D6CYP2C9CYP2C19RAB9A
SCHEMBL15827333 0.89 CYP3A4 (0.55) CYP3A4CYP2D6CYP2C9CYP2C19RAB9A
SCHEMBL2010522 0.85 CYP3A4 (0.53) CYP3A4CYP2D6CYP2C9CYP2C19RAB9A
SCHEMBL15827332 0.85 CYP3A4 (0.53) CYP3A4CYP2D6CYP2C9CYP2C19RAB9A
SCHEMBL2007693 0.84 CYP3A4 (0.52) CYP3A4CYP2D6CYP2C9CYP2C19RAB9A
SCHEMBL8387978 0.84 FOLH1 (0.65) FOLH1SIRT2SIRT1CTSLCTSS
SCHEMBL10421088 0.84 FOLH1 (0.62) FOLH1SIRT2SIRT1IDO1TDO2
SCHEMBL2640680 0.81 ALDH1A1 (0.51) IDO1MMP2MMP3MMP9MMP13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0699209-A1 PROCESSES AND INTERMEDIATE COMPOUNDS USEFUL FOR THE PREPARATION OF PLATELET GLYCOPROTEIN IIb/IIIa INHIBITORS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1996-03-06 EP disclosed
WO-1994026779-A1 PROCESSES AND INTERMEDIATE COMPOUNDS USEFUL FOR THE PREPARATION OF PLATELET GLYCOPROTEIN IIb/IIIa INHIBITORS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1994-11-24 WO disclosed